Omega-3 polyunsaturated fatty acids and docosahexaenoic acid appear to be associated with lower age-related macular ...
In Sonic the Hedgehog 3, Carrey has finally found a scene partner who can match his freak. It’s… Jim Carrey. One hook of this latest sequel is that it casts the actor in a dual role ...
Lytix Biopharma AS has successfully raised NOK 111.3 million through a private placement and a retail offering, settling the share loan arrangement with Saturn Invest by redelivering over 1.3 ...
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Lytix Biopharma AS has successfully raised NOK 111.3 million ...
For example, more than half of the biopharma executives Deloitte surveyed said their companies need to rethink their R&D and product development strategies over the next 12 months. Companies may ...
Overview: CSPC Innovation Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of biopharmaceuticals, APIs, and functional foods both in China and internationally ...
BEIJING, Dec. 19, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq ... Gross profit was RMB 307.3 million, with a gross margin of 82.6%, compared to RMB 220.9 million and an 80.9% ...
The National Biopharma Mission, launched in 2017, is in the process of revolutionising India's biopharmaceutical sector with a Rs 1,500 crore investment. Listen to Story India's bio-economy growth has ...
Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of pharma is going to be vying for capacity and talent. How do you get a bunch of ...
Note: BioSpace is taking a break for the holidays. The next episode of The Weekly will air Jan. 8, 2025. Happy New Year! On the clinical research side of the industry, 2024 saw its fair share of flops ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Lytix Biopharma AS has successfully raised NOK 111.3 million through a private placement and a retail offering ...